Latest filingSep 24, 2026Most recent Form 4
ABUS
Arbutus Biopharma Corp
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/24 to 09/24. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$04 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period20transactions
- M · Option exercise · dominant16 · 80%
- F · Tax withholding4 · 20%
Activity by reported role
A joint filing can contribute to multiple roles20transactions
- Director · dominant10 · 50%
- Chief financial officer5 · 25%
- PRES5 · 25%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (4)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeBeardsley Robert ACommon Shares · Direct
32,276Sep 18, 2026
Sawhney RogerCommon Shares · Direct
52,533Sep 18, 2026
Nguyen TuanCommon Shares · Direct
366,600Sep 18, 2026
Androski LindsayCommon Shares · Direct
72,337Sep 18, 2026
Beardsley Robert AStock Option (Right to Buy) · Direct
105,067Sep 18, 2026
Sawhney RogerStock Option (Right to Buy) · Direct
105,067Sep 18, 2026
Nguyen TuanStock Option (Right to Buy) · Direct
484,375Sep 18, 2026
Androski LindsayStock Option (Right to Buy) · Direct
194,014Sep 18, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 24 → Sep 24
LessMore
Top insiders
By absolute net value across the selected period- AL-$4
- SR-$3
- NT-$3
- BA-$1
Recent filing activity
Most recent 12 transactions · color = transaction code- MOption exercise09/24$0SEC
- MOption exercise09/24$0SEC
- FTax withholding09/24-$418kSEC
- MOption exercise09/24$45.9kSEC
- MOption exercise09/24$372kSEC
- MOption exercise09/24$0SEC
- MOption exercise09/24$0SEC
- FTax withholding09/24-$1.04MSEC
- MOption exercise09/24$120kSEC
- MOption exercise09/24$927kSEC
- MOption exercise09/24$0SEC
- MOption exercise09/24$0SEC
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
ABUS transaction history
Filters apply within this company and selected period by defaultLatest insider transactions
Form 4 filings from last month. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #228766 | ABUS | Androski Lindsay | PRES | exercise | 10.4k | $0 | M | 09/24 | 09/18 |
| #228765 | ABUS | Androski Lindsay | PRES | exercise | 116k | $0 | M | 09/24 | 09/18 |
| #228764 | ABUS | Androski Lindsay | PRES | withholding | 82.5k | -$41.8M | F | 09/24 | 09/18 |
| #228763 | ABUS | Androski Lindsay | PRES | exercise | 10.4k | $4.59M | M | 09/24 | 09/18 |
| #228762 | ABUS | Androski Lindsay | PRES | exercise | 116k | $37.2M | M | 09/24 | 09/18 |
| #228761 | ABUS | Nguyen Tuan | CFO | exercise | 27.4k | $0 | M | 09/24 | 09/18 |
| #228760 | ABUS | Nguyen Tuan | CFO | exercise | 265k | $0 | M | 09/24 | 09/18 |
| #228759 | ABUS | Nguyen Tuan | CFO | withholding | 206k | -$104M | F | 09/24 | 09/18 |
| #228758 | ABUS | Nguyen Tuan | CFO | exercise | 27.4k | $12.0M | M | 09/24 | 09/18 |
| #228757 | ABUS | Nguyen Tuan | CFO | exercise | 265k | $92.7M | M | 09/24 | 09/18 |
| #228756 | ABUS | Sawhney Roger | DIR | exercise | 78.8k | $0 | M | 09/24 | 09/18 |
| #228755 | ABUS | Sawhney Roger | DIR | exercise | 52.5k | $0 | M | 09/24 | 09/18 |
| #228754 | ABUS | Sawhney Roger | DIR | withholding | 100k | -$50.9M | F | 09/24 | 09/18 |
| #228753 | ABUS | Sawhney Roger | DIR | exercise | 78.8k | $33.4M | M | 09/24 | 09/18 |
| #228752 | ABUS | Sawhney Roger | DIR | exercise | 52.5k | $17.5M | M | 09/24 | 09/18 |
| #228751 | ABUS | Beardsley Robert A | DIR | exercise | 78.8k | $0 | M | 09/24 | 09/18 |
| #228750 | ABUS | Beardsley Robert A | DIR | exercise | 52.5k | $0 | M | 09/24 | 09/18 |
| #228749 | ABUS | Beardsley Robert A | DIR | withholding | 99.0k | -$50.2M | F | 09/24 | 09/18 |
| #228748 | ABUS | Beardsley Robert A | DIR | exercise | 78.8k | $33.4M | M | 09/24 | 09/18 |
| #228747 | ABUS | Beardsley Robert A | DIR | exercise | 52.5k | $16.8M | M | 09/24 | 09/18 |
Arbutus Biopharma Corp Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Arbutus Biopharma Corp?
Androski Lindsay, Nguyen Tuan, Sawhney Roger, Beardsley Robert A.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.